Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies

ABSTRACT: The purpose of this study is to compare the efficacy and safety of TAS-102 versus placebo in patients with refractory metastatic colorectal cancer.

DISEASE(S): Refractory Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Cancer Metastatic,Colorectal Neoplasms

PROVIDER: 2126073 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR